[Curative and preventive effect of Berenil afe oraland subcutaneous administration in experimental trypanosomiasis (Trypanoso rhodesiense, T.gambiense)].
D000085:Acetates / Q000627:therapeutic use; D000578:Amidines / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use; D003408:Cresols / Q000627:therapeutic use; D005998:Glycine / Q000627:therapeutic use; D051379:Mice; D010617:Phenanthridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011806:Quinolinium Compounds / Q000627:therapeutic use; D051381:Rats; D013498:Suramin / Q000627:therapeutic use; D014353:Trypanosomiasis, African / Q000188:drug therapy* / Q000517:prevention & control
D000085:Acetates; D000578:Amidines; D000981:Antiprotozoal Agents; D001391:Azo Compounds; D003408:Cresols; D010617:Phenanthridines; D011743:Pyrimidines; D011806:Quinolinium Compounds; D013498:Suramin; D005998:Glycine
urative und prophylaktcher Effek von Ber nah ora und subkutanerVerabreichungbei der experimentellen Trypanosomiasis (Trypanosoma rhodesiense, T. gambiense)